Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Pfizer Inc.    PFE

PFIZER INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Pfizer : On Pace for Highest Close Since July 2019 -- Data Talk

12/01/2020 | 12:50pm EST

Pfizer Inc. (PFE) is currently at $39.70, up $1.40 or 3.64%

-- Would be highest close since July 26, 2019, when it closed at $40.82

-- Would surpass the 2020 closing high of $38.56 set on Jan. 23, 2020, for the first time

-- On pace for largest percent increase since Nov. 9, 2020, when it rose 7.69%

-- Currently up four of the past five days

-- Currently up three consecutive days; up 8.69% over this period

-- Best three day stretch since the three days ending April 6, 2020, when it rose 8.88%

-- Up 6.98% year-to-date; on pace for best year since 2018, when it rose 20.51%

-- Down 16.24% from its all-time closing high of $47.40 on April 12, 1999

-- Up 10.15% from 52 weeks ago (Dec. 3, 2019), when it closed at $36.04

-- Would be a new 52 week closing high

-- Up 47.12% from its 52 week closing low of $26.99 on March 23, 2020

-- Traded as high as $40.50; highest intraday level since July 29, 2019, when it hit $40.73

-- Up 5.72% at today's intraday high; largest intraday percent increase since Nov. 9, 2020, when it rose as much as 15.36%

All data as of 12:29:43 PM

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

12-01-20 1249ET

All news about PFIZER INC.
08:14aTrading platform CMC says client activity eases in Q3
RE
08:06aPFIZER : Covid-19 - Nigeria Acquires Ultra Cold Freezers to Store Pfizer Vaccine
AQ
07:51aS.Korea in talks to secure 40 mln doses of Novavax's COVID-19 vaccine
RE
07:26aCOVID-19 vaccine shots add to confusion over China's tests for travellers
RE
07:00aCOVID-19 shots to cost $3 to $10 under African Union vaccine plan
RE
07:00aAu secured 100 mln doses of astrazeneca vaccine, manufactured by serum instit..
RE
04:13aASTRAZENECA : UK To Vaccinate Crucial COVID-19 Vaccine Supply Chain Employees Fo..
MT
01/19Brazil battles Chinese red tape to get active vaccine ingredients
RE
01/19PFIZER : Ford appeals to U.S. president-elect Biden for help securing more COVID..
AQ
01/19PFIZER : N.S. among provinces scrambling to adjust vaccination plans following P..
AQ
More news
Financials (USD)
Sales 2020 48 425 M - -
Net income 2020 19 798 M - -
Net Debt 2020 43 571 M - -
P/E ratio 2020 11,9x
Yield 2020 3,92%
Capitalization 204 B 204 B -
EV / Sales 2020 5,12x
EV / Sales 2021 4,44x
Nbr of Employees 88 300
Free-Float 59,1%
Chart PFIZER INC.
Duration : Period :
Pfizer Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 41,94 $
Last Close Price 36,73 $
Spread / Highest target 44,3%
Spread / Average Target 14,2%
Spread / Lowest Target -1,99%
EPS Revisions
Managers and Directors
NameTitle
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Suzanne Nora Johnson Independent Director
Helen H. Hobbs Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER INC.-0.22%204 160
JOHNSON & JOHNSON3.43%428 525
ROCHE HOLDING AG2.98%307 190
NOVARTIS AG2.24%218 823
MERCK & CO., INC.1.70%210 474
ABBVIE INC.4.69%198 051